Want to join the conversation?
$BXLT and $MNTA announced the initiation of a separate pivotal clinical trial of M923 in chronic plaque psoriasis in Oct.r 2015. $BXLT and $MNTA are targeting a first regulatory submission in 2017 and a first commercial launch as early as 2018.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.